WHO vaccine-preventable diseases: monitoring system. 2020 global summary

Last updated 15-July-2020 (data as of 12-October-2020)
Next overall update End 2020
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'2201 Infant (under 12 months) mortality rate: 362
GDP / capita (US$): 5'6371 Child (under 5 years) mortality rate: 492

Population data in thousands3

  2019  2018  2017  2016  2015  2000  1990  1980 
Total population 30'418  29'767  29'121  28'482  27'849  19'279  14'773  11'056 
Births 882  876  869  863  856  689  593  478 
Surviving infants 853  845  838  830  822  645  547  432 
Pop. less than 5 years 4'135  4'104  4'070  4'021  3'952  3'065  2'546  1'975 
Pop. less than 15 years 11'366  11'191  11'014  10'830  10'636  8'184  6'530  5'185 
Female 15-49 years 7'622  7'463  7'306  7'153  7'003  4'506  3'328  2'363 

Number of reported cases

(Click for retrospective incidence data for Ghana)
Diphtheria
ChartChart
  66  40 
Japanese encephalitis
 
Measles***
ChartChart
  1'274  34  19  32  23  23'068  32'246  82'684 
Mumps
ChartChart
  16'664  22'069  20'270  16'320 
Pertussis
ChartChart
  56  123  21  636  2'651  13'216 
Polio*
ChartChart
  18  104  60  145 
Rubella***
ChartChart
  18  24  17  11  12 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  80 
Tetanus (total)**
ChartChart
  20  270  538  1'214  219  660  1'045 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.
*** For 2019, if a country did not submit a joint reporting form, measles and rubella cases were sourced from data reported through the monthly surveillance data available from:
https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Ghana)
Vaccine year result method % card seen                                                
BCG 2016  94  MICS   88  96  98  99  94  97  95  71 
DTP1 2016  96  MICS   88  97  97  99  94  97  84 
DTP3 2016  91  MICS   88  97  97  99  93  89  84  50 
IPV1          97  55 
HepB_BD         
HepB3 2016  91  MICS   88  97  97  99  93  89 
Hib3 2016  91  MICS   88  97  97  99  93  89 
JapEnc         
MCV1          92  92  95  89  89  84  52  16 
MCV2          83  83  83  75  63 
MenA          79  83  82  13 
PCV1          97  98  99  94  93 
PCV2          97  96  99  94  91 
PCV3 2016  90  MICS   88  97  96  99  93  84 
Pol3 2016  88  MICS   88  97  98  94  95  84  83  50 
Rota1          95  96  99  94  92 
RotaC 2016  92  MICS   88  93  94  97  94  88 
RCV1          92  92  95  89  89 
TT2plus 2016  51  MICS   88  64  64  64  78  78  73  19 
PAB         
VAD1          77  91  90  90  76 
YFV 2016  82  MICS   88  92  91  86  88  88  74 
* indicates the country reported above 100% coverage.

  Next update: Mid July 2021

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Ghana)
BCG
ChartChart
  96  98  99  94  97  99  71 
DTP1
ChartChart
  97  97  99  94  97  96  80  27 
DTP3
ChartChart
  97  97  99  93  88  88  58 
HepB3
ChartChart
  97  97  99  93  88 
HepB_BD
 
Hib3
ChartChart
  97  97  99  93  88 
IPV1
ChartChart
  97  55 
MCV1
ChartChart
  92  92  95  89  89  90  61  16 
MCV2
ChartChart
  83  83  83  75  63 
PCV3
ChartChart
  97  96  99  93  88 
Pol3
ChartChart
  97  98  94  95  88  88  57 
RCV1
ChartChart
  92  92  95  89  89 
RotaC
ChartChart
  93  94  97  94  88 
YFV
ChartChart
  92  91  86  88  88  74 

Click to download WHO-UNICEF coverage estimates data for PAB time series.
Click to download WHO-UNICEF coverage estimates data for HPV time series.

Number of districts in the country 260  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 68
From 80 to 89% 14
From 50 to 79% 17
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2019 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
Measles 18 months; Yes
MenA_conj 18 months; Yes 12-23 months
MR 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10 weeks; Yes
RTS,S 6, 7, 9, 24 months; No from April 2019; 6-36 months
Td 1st contact; +1, +6 months; +1, +1 year; Yes 15-49 years
VitaminA 6, 12, 18, 24, 30, 36 months; Yes 6-59 months
YF 9 months; Yes

Immunization indicators

Indicator Expected answer 2019  2018  2017  2016  2015  2014  2013 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2015-2019  2015-2019  2015-2019  2015-2019  2010-2014  2010 - 2014 

System performance

Total Nº districts in country number 216  216  216  216  216  216  170 
Nº districts with DTP3 coverage >=80% number 185  186  187  175  164  162  136 
% of districts with DTP3 coverage >=80% From 0 to 100% 86  86  87  81  76  75  80 
Nº districts with measles (MCV1) coverage >=95% number 119  115  110  107  89  10  95 
% of districts with MCV1 coverage >=95% From 0 to 100% 55  53  51  50  41  56 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 30  35  40  24  19  16  13 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No  No  No 

Sources

 1  "The 2019 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  UN Inter-agency Group for Child Mortality Estimation (https://childmortality.org/data)  
 3  "United Nations, Population Division. The World Population Prospects - the 2019 revision". New York, 2019.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.